Pharmacodynamics is the branch of drug designing which includes the study of the biochemical and physiological effects of drugs on the body or on microorganisms or parasites within or on the body and the mechanisms of drug action and the relationship between drug concentration and effect. Pharmacodynamics is over and over again epitomized as the study of drugâs effect on the body. Pharmacodynamics is occasionally abbreviated as "PD". The notion of pharmacodynamics has been stretched to contain Multicellular Pharmacodynamics (MCPD). MCPD is the study of the static and dynamic properties and relationships between a set of drugs and a dynamic and diverse multicellular dimensional organization. It is the study of the mechanism of a drug on a negligible multicellular system (mMCS), together in vivo and in silico. Networked Multicellular Pharmacodynamics (Net-MCPD) further extends the perception of MCPD to represent regulatory genomic networks together with signal transduction pathways, as an element of a complex of interacting components in the cell. Antimicrobial pharmacodynamics is the connection between concentration of antibiotic and its capability to restrain vital processes of endo- or ectoparasites and microbial organisms. This branch of pharmacodynamics relates concentration of an anti-infective agent to effect, but specifically to its antimicrobial effect.
Last date updated on November, 2020